遵循实践指南与卵巢癌患者转诊时间缩短相关
该研究对2001至2014年单中心治疗的335例卵巢癌患者进行病历回顾,按美国国家综合癌症网络指南评估四项检查的依从性。结果显示65.7%患者检查依从指南,依从者转诊妇科肿瘤医生时间显著短于不依从者(20天 vs 86天,P<.001),但生存无显著差异(P=.103)。
要点
- 65.7%患者检查依从指南,34.3%不依从。
- 依从指南者转诊妇科肿瘤医生时间显著短于不依从者(20天 vs 86天,P<.001)。
- 仅23.9%患者的可疑盆腔肿块由妇产科发现,42.7%患者在转诊前未行肿瘤标志物检测。
核心结论
- 遵循指南的检查(包括肿瘤标志物检测)可缩短妇科肿瘤医生转诊时间,减少成本低效和延迟,指南应推广至妇产科领域以外。
研究设计与样本
- 对2001至2014年单中心治疗的卵巢癌患者进行病历回顾,共纳入335例符合标准的病例。
- 按美国国家综合癌症网络指南将检查分为提供者就诊、腹部/盆腔影像、胸部影像和肿瘤标志物四类,评估为依从或不依从指南。
主要发现
- 提供者就诊类83.9%患者检查依从指南,腹部/盆腔影像类77%,胸部影像类98.2%,肿瘤标志物类95.2%。
- 综合四类评估,65.7%患者检查依从指南,34.3%不依从。
- 依从指南者转诊妇科肿瘤医生时间显著短于不依从者(20天 vs 86天,P<.001)。
- 仅23.9%患者的可疑盆腔肿块由妇产科发现;42.7%患者在转诊妇科肿瘤医生前未行肿瘤标志物检测。
- 当妇产科专科医生发现可疑盆腔肿块时,转诊前其余检查更可能依从指南,与初始影像非妇产科专科医生开具相比(P=.18)。
关键数值与推荐
- 指南依从性按美国国家综合癌症网络指南四类检查评估:提供者就诊、腹部/盆腔影像、胸部影像和肿瘤标志物。
临床怎么用
- 遵循指南的检查(包括肿瘤标志物检测)可缩短妇科肿瘤医生转诊时间。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with ovarian cancer tend to receive the highest quality of care at high-volume cancer centers with gynecological oncologists. However, the care that they receive prior to gynecological oncology consult has not been examined. We investigated the quantity and quality of care given to patients with ovarian cancer before being seen by a gynecological oncologist. OBJECTIVE: We evaluated the variability, quantity, and quality of diagnostic testing and physician-referral patterns prior to consultation with a gynecological oncologist, in women with suspicious pelvic masses seen on imaging. STUDY DESIGN: A chart review was performed on patients treated for ovarian cancer at a single institution from 2001 to 2014. We evaluated their workup in 4 categories, drawn from National Comprehensive Care Network guidelines: provider visits, abdominal/pelvic imaging, chest imaging, and tumor markers. Workup was classified as guideline adherent or guideline nonadherent. RESULTS: We identified 335 cases that met our criteria. In the provider visit category, 83.9% of patients received guideline-adherent workup: 77% in the abdominal/pelvic imaging, 98.2% in the chest imaging, and 95.2% in the tumor marker categories. Each patient's workup was assessed as a compilation of the 4 categories, yielding 65.7% patients as having received an adherent workup and 34.3% of workup as nonadherent to guidelines. The timeframe to see a gynecological oncologist for patients with guideline-adherent workup was significantly shorter than for those whose workup was nonadherant (20 vs 86 days, P < .001). A suspicious pelvic mass was identified by obstetrics-gynecology in only 23.9% of patients; 42.7% of patients did not have tumor marker testing before a gynecological oncologist consult. When an obstetrics-gynecology specialist discovered the suspicious pelvic mass, the remaining workup was more likely to be guideline adherent prior to gynecological oncologist referral than when initial imaging was not ordered by an obstetrics-gynecology specialist (P = .18). Survival was not significantly different (P = .103). CONCLUSION: With a guideline-adherent workup, including tumor marker testing, gynecological oncologist referral times can be shortened, minimizing cost inefficiencies and delays that can compromise the effectiveness of downstream care for patients with ovarian cancer. Guidelines should be disseminated beyond the obstetrics-gynecology field.
引用
- Boac BM, Xiong Y, Apte SM, et al. Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer. Am J Obstet Gynecol. 2018. PMID: 29353030. doi:10.1016/j.ajog.2018.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。